Suppr超能文献

纯化的3β-羟基类固醇脱氢酶的脱氢酶和5-烯----4-烯异构酶活性的差异抑制。两个不同位点的证据。

Differential inhibition of dehydrogenase and 5-ene----4-ene isomerase activities of purified 3 beta-hydroxysteroid dehydrogenase. Evidence for two distinct sites.

作者信息

Luu-The V, Takahashi M, Labrie F

机构信息

MRC Group in Molecular Endocrinology, CHUL Research Center, Quebec, Canada.

出版信息

J Steroid Biochem Mol Biol. 1991;40(4-6):545-8. doi: 10.1016/0960-0760(91)90275-a.

Abstract

The success in synthesis of [3H]5-androstene-3,17-dione, the intermediate product in the transformation of DHEA to 4-androstenedione by 3 beta-hydroxysteroid dehydrogenase/5-ene----4-ene isomerase (3 beta-HSD) offers the opportunity to determine whether or not the two activities reside in one active site or in two closely related active sites. The finding that N,N-dimethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide (4-MA) inhibits competitively and specifically the dehydrogenase activity whereas a non-competitive inhibition type with a Ki value 1000 fold higher was observed for the isomerase activity, indicated that dehydrogenase and isomerase activities belong to separate sites. Using 5 alpha-dihydro-testosterone and 5 alpha-androstane-3 beta, 17 beta-diol, exclusive substrates for dehydrogenase activity, it was shown that dehydrogenase is reversible and strongly inhibited by 4-MA and that thus the irreversible step in the transformation of DHEA to 4-androstenedione is due to the isomerase activity.

摘要

[3H]5-雄甾烯-3,17-二酮的合成取得成功,该物质是脱氢表雄酮(DHEA)通过3β-羟基类固醇脱氢酶/5-烯→4-烯异构酶(3β-HSD)转化为4-雄烯二酮过程中的中间产物,这为确定这两种活性是存在于一个活性位点还是两个紧密相关的活性位点提供了契机。N,N-二甲基-4-甲基-3-氧代-4-氮杂-5α-雄甾烷-17β-甲酰胺(4-MA)竞争性且特异性地抑制脱氢酶活性,而异构酶活性则呈现出非竞争性抑制类型,其抑制常数(Ki)值高出1000倍,这一发现表明脱氢酶和异构酶活性属于不同的位点。使用5α-双氢睾酮和5α-雄甾烷-3β,17β-二醇(脱氢酶活性的专属底物),结果显示脱氢酶具有可逆性且受到4-MA的强烈抑制,因此DHEA转化为4-雄烯二酮过程中的不可逆步骤归因于异构酶活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验